Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Millett

Sports Medicine Vail, CO Medical Doctor

NPI 1700863990 CMS profile 213507

181 W Meadow Dr, Suite 400, Vail, CO 81657

Open in the dashboard

General payments

$21,641,001

318 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$27,733

1 holding reported · through program year 2025

Research they led as principal investigator

$547,851 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Peter Millett of Vail, CO is reported in the CMS Open Payments database as having received $21,641,001 across 318 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $547,851 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $27,733 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,484,925 30
2024 General $2,885,488 59
2023 General $2,472,142 29
2022 General $1,286,325 21
2021 General $2,241,819 64
2020 General $5,046,908 28
2019 General $4,223,393 87
2025 Ownership $27,733 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Millett
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Peter Millett were reported at $3,484,925. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Peter Millett Sports Medicine median Middle half National median
2019 $4,223,393 $1,176 $199–$4,249 $163
2020 $5,046,908 $708 $96–$2,890 $114
2021 $2,241,819 $1,213 $152–$3,994 $132
2022 $1,286,325 $1,230 $159–$3,998 $149
2023 $2,472,142 $584 $146–$2,836 $160
2024 $2,885,488 $628 $163–$3,168 $164
2025 $3,484,925 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $21,601,748 313 payments
  2. OsteoCentric Technologies, Inc. $39,000 1 payment
  3. Gemini Mountain Medical, LLC $220 2 payments
  4. Overture Orthopaedics $19 1 payment
  5. Ferring Pharmaceuticals Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $21,126,602 28 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $262,855 29 payments
  3. Consulting Fee $235,750 40 payments
  4. Travel and Lodging $11,099 70 payments
  5. Food and Beverage $4,677 150 payments
  6. Entertainment $19 1 payment
Products named General payments · program years 2019–2025
  1. SHOULDER IMPLANTS FIBERTAK KNOTLESS $9,106,635 10 payments
  2. SHOULDER IMPLANTS SPEEDBRIDGE COMPOSITE ANCHORS $9,105,128 8 payments
  3. SHOULDER IMPLANTS SPEEDBRIDGE PEEK ANCHORS $9,105,128 8 payments
  4. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ACHILLES $9,105,128 8 payments
  5. ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS $7,066,296 7 payments
  6. Arthrex Knee & Hip - Implants - Hip - Fibertak $4,653,461 7 payments
  7. ARTHREX Shoulder - Implants - Fibertak - Knotless $3,475,367 8 payments
  8. Arthrex Knee & Hip - Implants - Extra-Articular Lig & Patellofemoral - Knee FiberTak - Other $3,347,253 4 payments
  9. Arthrex Foot & Ankle and Trauma - Implants - Soft Tissue - Knotless Anchors - FiberTak $3,347,253 4 payments
  10. Arthrex Upper Extremity - Implants - Instability - FiberTak - Tensionable Knotless $3,347,253 4 payments
  11. Other $41,926,419 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

318 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record